Main Category: Diabetes
Article Date: 28 Jul 2013 - 1:00 PDT Current ratings for:
How Botox works could reveal diabetes secrets
Understanding the proteins that are targeted by the cosmetic drug Botox (onabotulinumtoxinA) could lead to breakthroughs against type 2 diabetes, according to researchers at Heriot-Watt University in Scotland.
The researchers are using new microscopic techniques on Soluble NSF Attachment Protein Receptor (SNARE) proteins with an aim of discovering how insulin is regulated and how this can change in the development of type 2 diabetes.
Botox targets SNARE proteins, preventing them from helping the muscles contract. But the proteins also exist in the beta-cells of the pancreas.
The research team plan to observe the SNARE proteins within the beta-cells of the pancreas, which help the beta-cells release the insulin by attempting to stabilize blood glucose levels.
The researchers say type 2 diabetes can develop in people who have long-term obesity, when the beta-cells are unable to cope with long-term high glucose levels and secrete less insulin. They add that this process means the beta-cells lose both mass and function, but the reasons for this are unknown. This is what the researchers will attempt to find out.
The organisation of SNARE proteins in a cell. The position of SNARE proteins is shown in purple with vesicles ready for release shown in green. Photo credit: Heriot-Watt University and the University of Edinburgh
Dr. Colin Rickman of the Heriot-Watt University told Medical News Today:
"The idea is that we want to look at these proteins and look at how they are arranged on the membrane, what they are doing, how they are interacting, and how they change the diabetic's history."
"Nobody has ever done this before," Dr. Colin Rickman added. He told MNT:
"The interesting angle is that we are going to use microscopy, which allows us to see the individual molecules in the cell.
Normally you just see a cell, but you can't see the individual proteins in the cell.
These techniques allow us to see tens of thousands of these molecules in the cell and look at how they are interacting and what they are up to."
Depending on the final results of the research, he says that the work could lead to new methods of diagnosing diabetes, and even lead to ways of preventing it through early risk identification.
Dr. Colin Rickman said:
A small cluster of SNARE proteins pinpointed using super-resolution microscopy. Each spot marks the position of an individual molecule. Photo credit: Heriot-Watt University and the University of Edinburgh
"Type 2 diabetes is usually caused by overconsumption of food and lack of exercise. People can live with obesity absolutely fine, until they reach that tipping point. But nobody really knows why the cells go through this tipping point.
"This research could enable us to understand how these processes are arranged and how it changes them to diabetic conditions.
"We could then use that as an assay to find out whether people are in danger of developing type 2 diabetes."
The team has already started preliminary investigations, analyzing the proteins and how they are arranged, but the biggest part of the study is yet to come in terms of analyzing different proteins and cells types and discovering the general principles of how they change.
Dr. Colin Rickman adds that further results will be ready by the end of this year and the full study should reach completion by the early part of 2015.
Written by Honor Whiteman
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our diabetes section for the latest news on this subject. There are no references listed for this article. Please use one of the following formats to cite this article in your essay, paper or report:
MLA
29 Jul. 2013.
Please note: If no author information is provided, the source is cited instead.
posted by ralphla54 on 28 Jul 2013 at 9:41 am
A new FDA approved diet pill called Belviq just went on the market. Belviq make people more likely to succeed with weight loss since they feel full more quickly and it reduces food cravings. People who take Belviq with diet and exercise were 2 times more likely to lose 5% body weight and 3 times more likely to lose 10% body weight than the people who just did diet and exercise alone. The label states that if you do not lose 5% of your body weight in 12 weeks then consider stopping. Those that do respond in 12 (about 45% of patients) weeks go on to lose over 10% of their body weight in one year. Losing 22 pounds for a 220 pound person is life changing. So 45% of those taking Belviq lose significant amount of weight.
Belviq has a second mode of action to reduce blood sugar which may end up preventing diabetes in many cases. Diabetics and pre-diabetics who took Belviq, REGARDLESS of weight loss, saw their blood sugar numbers drop by double digit percentages. IE HbA1c -0.9 to -1.2 and fasting glucose feel -27. The cost of medications to reduce HbA1c levels exceeds the cost of Belviq. (seeArena's BloomDM phase III trial) These reductions in diabetic symptoms plus the weight loss at the same time makes Belviq a medical bargain.
| post followup | alert a moderator |
'How Botox works could reveal diabetes secrets'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
No comments:
Post a Comment